Pancreatic cancer is a highly aggressive and difficult-to-detect cancer with a poor prognosis.
Late diagnosis is common due to a lack of early symptoms, specific markers, and the …

Cancer screening and diagnosis with the utilization of innovative Artificial Intelligence tools
improved the treatment strategies and patients' survival. With the rapid development of …

Timely detection is crucial to improve PDAC patients' outcomes, because the 5-year survival
increases from only 3% in metastatic patients to 42% when the tumor is still confined to the …

Purpose This study aims to introduce an innovative multi-step pipeline for automatic tumor-
stroma ratio (TSR) quantification as a potential prognostic marker for pancreatic cancer …

Pancreatic ductal adenocarcinoma (PDAC) stands out as the predominant malignant
neoplasm affecting the pancreas, characterized by a poor prognosis, in most cases patients …

Pancreatic ductal adenocarcinoma (PDAC) is the most common malignant tumor of the
pancreas, carrying a poor prognosis, in most cases patients being diagnosed in a …

Purpose This study aims to introduce an innovative multi-step pipeline for automatic
tumorstroma ratio (TSR) quantification as a potential prognostic marker for pancreatic …

This thesis addresses optimization of the interpretation and applicability of tumor markers
such as carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) in …